Internal Medicine, Hematology & Oncology · Lakeland, FL
NPI
1659376192
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3525 Lakeland Hills Blvd
Lakeland, FL, 33805
Phone (863) 603-6565
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
3,377 services
Medicare patients, 2024
265
Average age 75
Drug cost, 2024
$7.5M
2,086 prescriptions
Company payments, 2025
$482
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kamal Haider was code 85025 (blood count), 889 times for 173 patients. In total Kamal Haider billed 3,377 services in 43 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 889 | 173 | $7.61 | $6,765 |
| 80053 Clinical Chemistry | Office | 763 | 161 | $10.35 | $7,897 |
| 99214 Office E&M - Established | Office | 604 | 159 | $82.39 | $50K |
| 99232 Hospital E&M - Subsequent | Facility | 175 | 54 | $60.88 | $11K |
| 36415 Venipuncture Blood Collection | Office | 157 | 66 | $7.80 | $1,224 |
| 99213 Office E&M - Established | Office | 128 | 91 | $52.56 | $6,727 |
| 99215 Office E&M - Established | Office | 90 | 40 | $128.21 | $12K |
| 84153 Clinical Chemistry | Office | 55 | 17 | $18.02 | $991 |
| 80048 Clinical Chemistry | Office | 45 | 25 | $8.29 | $373 |
| 83615 Clinical Chemistry | Office | 38 | 21 | $5.92 | $225 |
| 85610 Clinical Chemistry | Office | 29 | 24 | $4.20 | $122 |
| 85027 Blood Count | Office | 28 | 12 | $6.34 | $178 |
| 85007 Blood Count | Office | 27 | 11 | $3.72 | $100 |
| 85730 Clinical Chemistry | Office | 25 | 22 | $5.89 | $147 |
| 84443 Clinical Chemistry | Office | 23 | 14 | $16.46 | $379 |
By year: 2022 $108K for 3,255 services; 2023 $123K for 3,370 services; 2024 $108K for 3,377 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 889 | 173 | $7.61 | $6,765 |
| 80053 Clinical Chemistry | 763 | 161 | $10.35 | $7,897 |
| 36415 Venipuncture Blood Collection | 157 | 66 | $7.80 | $1,224 |
| 84153 Clinical Chemistry | 55 | 17 | $18.02 | $991 |
| 80048 Clinical Chemistry | 45 | 25 | $8.29 | $373 |
| 83615 Clinical Chemistry | 38 | 21 | $5.92 | $225 |
| 85610 Clinical Chemistry | 29 | 24 | $4.20 | $122 |
| 85027 Blood Count | 28 | 12 | $6.34 | $178 |
| 85007 Blood Count | 27 | 11 | $3.72 | $100 |
| 85730 Clinical Chemistry | 25 | 22 | $5.89 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Kamal Haider prescribed most often to Medicare patients was Anastrozole, with 215 prescriptions and refills. In total Kamal Haider wrote 2,086 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 215 | 501 | 62 | $2,641 |
| Dexamethasone Generic | 111 | 113 | 38 | $1,537 |
| Abiraterone Acetate Generic | 96 | 96 | 12 | $240K |
| Prednisone Generic | 96 | 136 | 36 | $393 |
| Ondansetron Hcl Generic | 95 | 100 | 53 | $1,384 |
| Letrozole Generic | 92 | 205 | 29 | $2,318 |
| Potassium Chloride Generic | 83 | 118 | 21 | $1,348 |
| Prochlorperazine Maleate Generic | 79 | 81 | 55 | $808 |
| Pomalyst Pomalidomide | 53 | 53 | Under 11 | $1.1M |
| Nubeqa Darolutamide | 48 | 50 | Under 11 | $703K |
| Hydroxyurea Generic | 45 | 95 | 12 | $1,289 |
| Eliquis Apixaban | 43 | 61 | 12 | $34K |
| Oxycodone Hcl Generic | 42 | 42 | 18 | $775 |
| Ondansetron Odt Ondansetron | 40 | 40 | 23 | $663 |
| Imatinib Mesylate Generic | 36 | 36 | Under 11 | $21K |
Brand drugs: 522 claims; generic drugs: 1,564 claims; opioid claims: 164.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kamal Haider $482 ($482 in general payments such as food, travel and fees) from 9 companies. The largest payer was Jazz Pharmaceuticals Inc. with $138.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $138 |
| Abbvie Inc. ABBV | 3 | $101 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $76.29 |
| Pfizer Inc. PFE | 3 | $70.04 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $22.03 |
| Genentech USA, Inc. ROG.SW | 1 | $20.94 |
| Genzyme Corporation SNY | 1 | $18.11 |
| Amgen Inc. AMGN | 1 | $17.99 |
| Stemline Therapeutics Inc. | 1 | $17.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.